RIPK1 and bacterial infectious disease: It is now known that TAK1 is a negative regulator of PANoptosis, and that inhibition of TAK1 combined with innate immune priming, such as LPS treatment or bacterial infection, mediates RIPK1-dependent PANoptosis (17, 35).